Skip to content
Home/Companies/Biotech/ExcellGene
EX

ExcellGene

Biotech·Switzerland·Active·1yr hold

ExcellGene is a life science tools & biologic services company, headquartered in Switzerland.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns ExcellGene?

ExcellGene is currently owned by ARCHIMED through MED Rise (2024 vintage), since 2025.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Rise · 2024 · Buyout

Key facts

HQSwitzerland
SectorLife Science Tools & Biologic Services

More from MED Rise

Other portfolio companies in the same fund.

IRAB
Active
PharmaSpain· 2026
Arkstone
Active
HealthTechUS· 2025
Ceva Animal Health
Active
HealthcareFrance· 2025
Groupe Laboratoire Rivadis
Active
HealthTechFrance· 2025
ZimVie
Active
MedTechUS· 2025
Biodextris
Active
BiotechCanada· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings